Ambiq Micro, Inc.
For the period ended Sep 30, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 10, 2026
AMBQ$45.24-1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) (UNAUDITED)
For the three and nine months ended September 30, 2026 and 2025
(in thousands, except share amounts)
| Redeemable ConvertiblePreferred Stock · Common Stock · AdditionalPaid- · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’ | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | In-Capital | Deficit | Income (Loss) | Equity (Deficit) | |
| Balance June 30, 2025 | 341,496,158 | $378,150 | 450,682 | $— | $30,159 | $(337,030) | $(440) | $(307,311) |
| Conversion of redeemable convertible preferred stock into common stock in connection with initial public offering | (341,496,158) | (378,150) | 12,729,240 | — | 378,150 | — | — | 378,150 |
| Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions | — | — | 4,600,000 | — | 99,843 | — | — | 99,843 |
| Settlement of warrant liability | — | — | — | — | 173 | — | — | 173 |
| Exercise of warrants | — | — | 435,013 | — | 5,702 | — | — | 5,702 |
| Exercise of stock options | — | — | 23,527 | — | 178 | — | — | 178 |
| Stock-based compensation | — | — | — | — | 2,068 | — | — | 2,068 |
| Currency translation adjustment | — | — | — | — | — | — | (14) | (14) |
| Net Loss | — | — | — | — | — | (9,002) | — | (9,002) |
| Balance September 30, 2025 | — | $— | 18,238,462 | $— | $516,273 | $(346,032) | $(454) | $169,787 |
| Balance June 30, 2026 | — | $— | 24,146,260 | $— | $778,920 | $(373,997) | $(251) | $404,672 |
| Exercise of stock options | — | — | 356,787 | — | 3,794 | — | — | 3,794 |
| RSUs vested | — | — | 13,596 | — | — | — | — | — |
| Stock-based compensation | — | — | — | — | 4,017 | — | — | 4,017 |
| Currency translation adjustment | — | — | — | — | — | — | (50) | (50) |
| Net loss | — | — | — | — | — | (7,056) | — | (7,056) |
| Balance September 30, 2026 | — | $— | 24,516,643 | $— | $786,731 | $(381,053) | $(301) | $405,377 |
| Redeemable ConvertiblePreferred Stock · Common Stock · AdditionalPaid- · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’ | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | In-Capital | Deficit | Income (Loss) | Equity (Deficit) | |
| Balance January 1, 2025 | 341,496,158 | $378,150 | 434,720 | $— | $28,368 | $(320,250) | $(520) | $(292,402) |
| Conversion of redeemable convertible preferred stock into common stock in connection with initial public offering | (341,496,158) | (378,150) | 12,729,240 | — | 378,150 | — | — | 378,150 |
| Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions | — | — | 4,600,000 | — | 99,843 | — | — | 99,843 |
| Settlement of warrant liability | — | — | — | — | 173 | — | — | 173 |
| Exercise of warrants | — | — | 435,013 | — | 5,702 | — | — | 5,702 |
| Exercise of stock options | — | — | 39,489 | — | 353 | — | — | 353 |
| Stock-based compensation | — | — | — | — | 3,684 | — | — | 3,684 |
| Currency translation adjustment | — | — | — | — | — | — | 66 | 66 |
| Net loss | — | — | — | — | — | (25,782) | — | (25,782) |
| Balance September 30, 2025 | — | $— | 18,238,462 | $— | $516,273 | $(346,032) | $(454) | $169,787 |
| Balance January 1, 2026 | — | $— | 18,316,928 | $— | $519,610 | $(356,711) | $(440) | $162,459 |
| Issuance of common stock in connection with follow-on offerings, net of deferred offering costs, underwriting discounts and commissions | — | — | 4,936,651 | — | 243,282 | — | — | 243,282 |
| Exercise of warrants | — | — | 238,931 | — | 3,010 | — | — | 3,010 |
| Exercise of stock options | — | — | 922,026 | — | 9,893 | — | — | 9,893 |
| RSUs vested | — | — | 102,107 | — | — | — | — | — |
| Stock-based compensation | — | — | — | — | 10,936 | — | — | 10,936 |
| Currency translation adjustment | — | — | — | — | — | — | 139 | 139 |
| Net loss | — | — | — | — | — | (24,342) | — | (24,342) |
| Balance September 30, 2026 | — | $— | 24,516,643 | $— | $786,731 | $(381,053) | $(301) | $405,377 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.